Bio-Techne Corporation

NasdaqGS:TECH

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Chemicals & Advanced Materials

🩺 Medical Instruments

Location

United States

Market Cap

USD 7.86 B

Share Price

USD 49.89

Avg Daily Volume

2,353,179

Change (1 day)

-0.48%

Change (1 year)

-33.06%

Change (YTD)

-30.74%

Bio-Techne Corporation Enterprise Value to EBITDA (EV/EBITDA) on June 20, 2025: 28.52

Bio-Techne Corporation Enterprise Value to EBITDA (EV/EBITDA) is 28.52 on June 20, 2025, a -12.43% change year over year. EV/EBITDA ratio compares the enterprise value to the EBITDA; lower suggests more favorable company valuation.

Bio-Techne Corporation 52-week low Enterprise Value to EBITDA (EV/EBITDA) is 37.88 on June 20, 2025, which is 32.84% above the current Enterprise Value to EBITDA (EV/EBITDA).
Bio-Techne Corporation 52-week low Enterprise Value to EBITDA (EV/EBITDA) is 26.73 on June 20, 2025, which is -6.28% below the current Enterprise Value to EBITDA (EV/EBITDA).
Bio-Techne Corporation average Enterprise Value to EBITDA (EV/EBITDA) for the last 52 weeks is 32.45.

Daily

From:

To:

Zoom:

Key data

Date	Enterprise Value to EBITDA (EV/EBITDA)	Free Cash Flow Yield	Dividend Yield	Market Capitalization

NasdaqGS: TECH

Bio-Techne Corporation

CEO	Mr. Kim Kelderman
IPO Date	Feb. 9, 1989
Location	United States
Headquarters	614 McKinley Place N.E.
Employees	3,100
Sector	🏥 Health Care
Industries Biotechnology 🔬 Chemicals & Advanced Materials 🩺 Medical Instruments

Description

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. It offers its products under R&D Systems, Tocris Biosciences, Novus Biologicals, ProteinSimple, Advanced Cell Diagnostics, Exosome Diagnostics, and Asuragen brands. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was founded in 1976 and is headquartered in Minneapolis, Minnesota.

Similar companies

DHR

Danaher Corporation

USD 196.39

1.00%

Agilent Technologies, Inc.

USD 115.56

0.03%

600010.SS

Inner Mongolia Baotou Steel Union Co., Ltd.

USD 0.24

0.40%

QGEN

Qiagen N.V.

USD 46.76

0.45%

BRKR

Bruker Corporation

USD 38.08

-0.91%

TECN.SW

Tecan Group AG

USD 196.01

-0.72%

688068.SS

Beijing Hotgen Biotech Co., Ltd.

USD 18.59

-1.19%

688289.SS

Sansure Biotech Inc.

USD 2.83

2.01%

EUZ.DE

Eckert & Ziegler Strahlen- und Medizintechnik AG

USD 73.33

0.48%

RO.SW

Roche Holding AG

USD 336.78

-0.52%

ABT

Abbott Laboratories

USD 132.99

0.44%

BSX

Boston Scientific Corporation

USD 101.30

-0.07%

TMO

Thermo Fisher Scientific Inc.

USD 397.88

1.35%

4519.T

Chugai Pharmaceutical Co., Ltd.

USD 49.19

-0.68%

SHL.DE

Siemens Healthineers AG

USD 53.26

0.96%

MRK.DE

MERCK Kommanditgesellschaft auf Aktien

USD 127.08

1.48%

BDX

Becton, Dickinson and Company

USD 168.42

-0.10%

GEHC

GE HealthCare Technologies Inc.

USD 71.28

-0.85%

4543.T

Terumo Corporation

USD 17.95

-0.20%

4901.T

FUJIFILM Holdings Corporation

USD 21.10

-0.92%

NTRA

Natera, Inc.

USD 171.86

0.52%

DIM.PA

Sartorius Stedim Biotech S.A.

USD 231.80

-0.35%

Laboratory Corporation of America Holdings

USD 261.88

0.19%

WAT

Waters Corporation

USD 342.63

0.96%

BIM.PA

bioMérieux S.A.

USD 138.60

1.42%

HLMA.L

Halma plc

USD 41.53

-1.34%

WST

West Pharmaceutical Services, Inc.

USD 215.82

-0.98%

BAX

Baxter International Inc.

USD 29.99

0.64%

IEX

IDEX Corporation

USD 173.15

-1.07%

SN.L

Smith & Nephew plc

USD 14.50

0.27%

RVTY

Revvity, Inc.

USD 94.99

0.61%

603392.SS

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

USD 8.66

2.02%

6869.T

Sysmex Corporation

USD 16.78

0.31%

EXAS

Exact Sciences Corporation

USD 53.02

1.30%

AVTR

Avantor, Inc.

USD 13.57

2.11%

CTEC.L

ConvaTec Group Plc

USD 3.81

1.16%

GMED

Globus Medical, Inc.

USD 57.87

0.87%

AUROPHARMA.NS

Aurobindo Pharma Limited

USD 12.66

1.46%

4188.T

Mitsubishi Chemical Group Corporation

USD 5.13

-0.92%

7701.T

Shimadzu Corporation

USD 24.15

-2.07%

RGEN

Repligen Corporation

USD 118.85

1.11%

300832.SZ

Shenzhen New Industries Biomedical Engineering Co., Ltd.

USD 8.10

-0.68%

BIO

Bio-Rad Laboratories, Inc.

USD 236.74

2.04%

DIA.MI

DiaSorin S.p.A.

USD 108.71

1.66%

000100.KS

Yuhan Corporation

USD 75.65

3.64%

3347.HK

Hangzhou Tigermed Consulting Co., Ltd.

USD 4.61

-0.28%

LNTH

Lantheus Holdings, Inc.

USD 79.19

0.25%

3759.HK

Pharmaron Beijing Co., Ltd.

USD 1.95

0.66%

688617.SS

APT Medical Inc.

USD 38.32

1.54%

BANB.SW

Bachem Holding AG

USD 71.24

1.58%

StockViz Staff

June 21, 2025

Any question? Send us an email